AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 6, n. 1, p. e2014047, 2014. DOI: 10.4084/mjhid.2014.047. Disponível em: https://www.mjhid.org/mjhid/article/view/2014.047. Acesso em: 2 jun. 2026.